The Latest Breaking News from Pfizer

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.22%. Stocks this morning are posting modest gains, with the...

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are up +0.17%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are up +0.31%. Stock index futures this morning are moderately higher after the U.S. Nov CPI report matched expectations and eased slightly, bolstering speculation the Fed will start cutting interest...

Two new COVID-19 vaccines targeting the new Omicron variant of the virus are now available in Australian pharmacies around the nation.

Antitrust overreach is hurting America's global competitiveness, with the FTC calculating industry concentration on a purely domestic basis.

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Dr David Brown says erectile dysfunction drug, subject of a BBC drama, could have been scrapped if a miner hadn’t spoken out

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.50%. Stocks this morning are mixed, with the Dow Jones...

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

Pfizer said Friday it would not advance development of a twice-daily oral weight-loss drug because of its side effects.

State attorney general Ken Paxton files suit despite medical consensus that vaccine prevents severe infection and death

The Innovator IBD 50 ETF outperformed with a 0.6% gain and could make its first close above the 200-day moving average since Sept. 12.